Literature DB >> 11555724

Cytokine gene polymorphisms relevant for the spondyloarthropathies.

M Rudwaleit1, T Höhler.   

Abstract

Results of sibling and twin studies suggest that a substantial proportion of susceptibility to spondyloarthropathies arises from genes outside the human leukocyte antigen (HLA) region. There is increasing evidence that the pattern of cytokine secretion influences the course of spondyloarthropathies. A Th2 cytokine pattern (low tumor necrosis factor [TNF]-TNF-alpha low interferon [IFN]-gamma, and high interleukin [IL]-10) dominates in the joints of reactive arthritis patients. For IL-10 and TNF-alpha a substantial proportion of cytokine production is under genetic control and influenced by genetic polymorphisms. Here we review the evidences for association of TNF-alpha and IL-10 polymorphisms with spondyloarthropathies and their functional implications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555724     DOI: 10.1097/00002281-200107000-00002

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  7 in total

1.  The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bing Li; Pei Wang; Hui Li
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

2.  Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia.

Authors:  C Romero-Sánchez; J Londoño; G Delgado; D A Jaimes; J De Avila; A Mora; M Avila; J Castellanos; I Briceño; R Valle-Oñate
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

3.  A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.

Authors:  Anna Rita Giardina; Angelo Ferrante; Francesco Ciccia; Rosalia Impastato; Maria Concetta Miceli; Alfonso Principato; Giovanni Triolo
Journal:  Rheumatol Int       Date:  2009-10-23       Impact factor: 2.631

Review 4.  Ankylosing spondylitis: an overview.

Authors:  J Sieper; J Braun; M Rudwaleit; A Boonen; A Zink
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

5.  Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.

Authors:  P T Yang; H Kasai; L J Zhao; W G Xiao; F Tanabe; M Ito
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  Effect of Interferon-γ Polymorphisms on Ankylosing Spondylitis: A Case-Control Study.

Authors:  Haitao Xu; Bo Li
Journal:  Med Sci Monit       Date:  2017-08-26

Review 7.  Advances in nanomedicine for the treatment of ankylosing spondylitis.

Authors:  Yanhai Xi; Tingwang Jiang; Birendra Chaurasiya; Yanyan Zhou; Jiangmin Yu; Jiankun Wen; Yan Shen; Xiaojian Ye; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2019-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.